News for 'NCE'

Glenmark may become first Indian firm with NCE

Glenmark may become first Indian firm with NCE

Rediff.com9 Nov 2010

Glenmark and its partners today said Crofelemer, a first-in-class (first of its kind) anti-diarrhoeal drug for HIV-associated diarrhoea, had successfully completed the third and final phase of clinical trials.

Gukesh holds Ding: Chess C'ship heads for dramatic finale

Gukesh holds Ding: Chess C'ship heads for dramatic finale

Rediff.com11 Dec 2024

The draw left both players on an identical tally of 6.5 points each, with just one game left in the 14-round classical time control format, still shy of 1 point in order to win the title.

Chess C'ship: Gukesh's miscalculation costs him Game 1

Chess C'ship: Gukesh's miscalculation costs him Game 1

Rediff.com25 Nov 2024

D Gukesh paid dearly for unwarranted complications in the middle game, allowing defending champion Ding Liren of China to clinch the opening game

Margin, demand woes may deflate tyre makers

Margin, demand woes may deflate tyre makers

Rediff.com28 Mar 2024

The margins of tyre manufacturers could come under pressure given the rise in rubber prices and the moderating demand for tyres. In the past three quarters, the revenue growth for listed tyre companies has moderated from low to mid-single-digit on account of factors such as lower demand in replacement segments, weak export markets and the decline in the average selling prices to car makers (OEMs). Demand trends could remain muted in the near term, given the weak passenger vehicle replacement demand, assuming a typical replacement cycle of 3-5 years, and demand moderation in the OEM segment.

Ranbaxy first Indian co to launch NCE

Ranbaxy first Indian co to launch NCE

Rediff.com5 Sep 2007

Ranbaxy has completed the second phase of the clinical trial of a revolutionary anti-malarial drug that could enable it to be the nation's first pharmaceutical company to launch a New Chemical Entity globally.

India Inc takes mental health to heart

India Inc takes mental health to heart

Rediff.com12 Dec 2022

Work-related stress can impact one's mental health. Which is why Saurabh Tiwari says he's fortunate that his company understands this and is doing whatever it can to help mitigate that stress. "My company provides opportunities according to my interest, and if anyone is feeling stressed or has additional workload, they can talk with their supervisor to resolve it," says the 31-year-old who's working from home for a Bengaluru-based IT firm. Not everyone's as lucky.

Pak to raise defence spend by Rs 83 bn; forces to get Rs 1.4 tn in budget

Pak to raise defence spend by Rs 83 bn; forces to get Rs 1.4 tn in budget

Rediff.com5 Jun 2022

The increased amount, defence sources say, will be consumed mostly by the allocation for employees-related expenses, salaries and allowances of servicemen.

Reliance Retail acquires sole control of Just Dial

Reliance Retail acquires sole control of Just Dial

Rediff.com2 Sep 2021

Billionaire Mukesh Ambani-led Reliance Retail on Thursday said it has acquired sole control of 25-year-old search and discovery firm Just Dial. The firm's subsidiary Reliance Retail Ventures Ltd had in July announced a deal to buy a controlling stake in Just Dial for Rs 3,497 crore. Further to that announcement, "RRVL has now taken sole control of Just Dial Ltd in accordance with the SEBI Takeover Regulations with effect from September 1, 2021."

90% chipmakers have design footprint in India: Intel

90% chipmakers have design footprint in India: Intel

Rediff.com16 Nov 2021

As many as 2,000 chips are annually designed in India by semi-conductor and fabless companies, Intel India managing director Prakash Mallya said in a conversation with Business Standard. Mallya was reiterating the importance of India in the semi-conductor sweepstakes. "As much as 90 per cent of the semi-conductor companies have a design footprint in India.

IPO frenzy continues; 2 public issues to open on Sep 1

IPO frenzy continues; 2 public issues to open on Sep 1

Rediff.com29 Aug 2021

The IPO rush will continue in September with two more companies Vijaya Diagnostic Centre and Ami Organics launching their initial share-sales on Wednesday to raise a total of Rs 2,465 crore. This comes after eight companies including Devyani International, Nuvoco Vistas Corporation and CarTrade Tech floated their initial share-sales last month to mobilise Rs 18,243 crore. So far in the current fiscal, a total of 20 companies have mopped up more than Rs 45,000 crore through IPOs. This is much higher than Rs 31,277 crore raised by 30 firms in the entire 2020-21.

Meet FM's A-team behind Budget 2022

Meet FM's A-team behind Budget 2022

Rediff.com31 Jan 2022

Finance Minister Nirmala Sitharaman will present the much-awaited 2022-23 Union Budget on February 1. While there has been strong recovery in some sectors, touch services like hospitality, tourism and leisure continue to suffer after two Covid-19 waves. Household savings have been hit due to increased spending on health care. Consumption has still not reached pre-pandemic levels.

Will 5G turn the tables for India's telecom companies?

Will 5G turn the tables for India's telecom companies?

Rediff.com30 Mar 2022

Consumers can expect a 5G launch in the country soon. Telecom companies (telcos) say if auctions take place on time - the target is July - they would be able to offer some services in a few cities by the end of this year and a full roll-out from 2023. But the question is: will 5G turn the tables for telcos financially? Will average revenue per user (ARPU) improve? Will mobile consumers upgrade to 5G quickly and pay more? Will the expanded functions that 5G enables drum up sufficient revenues? In simple terms, will telcos make more money?

India's fuel pricing mechanism is opaque and removed from reality

India's fuel pricing mechanism is opaque and removed from reality

Rediff.com5 Apr 2022

What could be more uncertain than Virat Kohli's agonising wait for a century for over two years? Perhaps it's what you will pay tomorrow morning to fill your vehicle's tank. Pump prices have joined cricket scores as the country's favourite discussion topic. Steep increases invite widespread protests, while moderate additions make the government anti-reformist. The ongoing fuel price conundrum is no different.

Sebi eases valuation norms for AT-1 bonds

Sebi eases valuation norms for AT-1 bonds

Rediff.com24 Mar 2021

The Securities and Exchange Board of India (Sebi) on Monday relaxed the norms for valuing perpetual bonds. The norms, which had sought to value banks' deemed residual maturity of Basel III additional tier 1 (AT1) bonds as 100-year debt from April 1, were strongly opposed by the finance ministry. In a statement released on Monday, the regulator said the maturity would be 10 years until March 31, 2022, and would be increased to 20 and 30 years over the subsequent six-month period.

Will the entry of PEs into banks lead to better governance?

Will the entry of PEs into banks lead to better governance?

Rediff.com24 Mar 2022

Private equity (PE) is set to play a bigger role in banks. Of 21 recommendations accepted by the Reserve Bank of India (RBI) out of 31 made by its Internal Working Group (IWG), its stance on non-promoter holdings in private banks is seen with excitement, though it doesn't refer to PEs explicitly. On non-promoter holdings in these banks, the RBI said this will be capped at 10 per cent of the paid-up voting equity share capital in the case "of natural persons and non-financial institutions and entities"; and "at 15 per cent for all categories of financial institutions, entities, supranational institutions, public sector undertaking, or the government." While this is a modification of the IWG's stance for the non-promoter holding in banks at up to 15 per cent, it does open up a huge window for PEs, all the same. This is because, while the RBI has remained silent on the eligibility of industrial houses for bank licences, fresh high-quality capital in large amounts can only come from PEs.

Pharma majors to invest in drug discovery

Pharma majors to invest in drug discovery

Rediff.com11 Feb 2008

Pharma majors are collaborating with foreign companies to develop newer drugs.

This may hurt Indian drug firms

This may hurt Indian drug firms

Rediff.com28 Nov 2005

Indian pharma majors take a dose of new molecule

Indian pharma majors take a dose of new molecule

Rediff.com19 Feb 2007

There is a cluster of three buildings in Gurgaon that one can easily lose in the landscape of this Delhi suburb. But once inside, you cannot miss the smell of white powder or the rustle of some 1,400 lab coats.

IL&FS case reveals what India's resolution mechanism is lacking

IL&FS case reveals what India's resolution mechanism is lacking

Rediff.com1 May 2021

The infra-major going belly up cracked open some major flaws in the system - the most evident being weak corporate governance and how layers of corporate structures could be formed adding to the opaqueness of the group.

When a fan paid for Afridi's meal...

When a fan paid for Afridi's meal...

Rediff.com12 Jan 2016

Pakistan's Twenty20 captain Shahid Afridi was saved of much embarrassment when a fan stepped in to pay for his meal at a fast food joint in Auckland, after the flamboyant cricketer realised that he was not carrying local currency.

'It was very hard to build an R&D set-up in India'

'It was very hard to build an R&D set-up in India'

Rediff.com25 Jul 2017

Sohini Das chats with MD of Zydus Cadila Healthcare Pankaj R Patel & his son Sharvil Patel.

The heart interview you must read

The heart interview you must read

Rediff.com26 Apr 2019

Advice for a healthy heart from one of India's top heart surgeons.

Markets end flat amid volatile trade

Markets end flat amid volatile trade

Rediff.com3 Nov 2014

Custodian banks are selling dollars for their foreign fund clients.

6 months of Modi govt: Six biggest strengths

6 months of Modi govt: Six biggest strengths

Rediff.com25 Nov 2014

Steps taken by the government over the past few months signal a determined effort to reform the subsidy regime.